
Join to view full profile
Massachusetts General Hospital55 Fruit St.Boston, MA 02114
Phone+1 617-726-2865
Dr. Wallace is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard T.H. Chan School of Public HealthM.Sc., Epidemiology, 2014 - 2017
Mass General Brigham/Massachusetts General HospitalFellowship, Rheumatology, 2013 - 2015
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2010 - 2013
Georgetown University School of MedicineClass of 2010
Cornell UniversityB.A., History, Distinction in All Subjects, 2002 - 2006
Certifications & Licensure
ME State Medical License Current
MA State Medical License 2012 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Publications & Presentations
PubMed
- B-Cell Depletion Relative to Tumor Necrosis Factor Inhibition Extends the Duration of Viral Shedding in COVID-19 Among Autoimmune Disease Patients: A Matched Prospecti...Liya Sisay Getachew, Xiaosong Wang, Naomi J Patel, Zachary S Wallace, Lauren A O'Keeffe
ACR Open Rheumatology. 2026-08-01 - Broad screening of inflammation-associated proteins identifies serum CCL19 as a novel biomarker of disease activity in IgG4-related disease.Federica Bonaso, Bohang Jiang, Laura J Yockey, Jesse Akaa, Ian Doyle
Annals of the Rheumatic Diseases. 2026-05-13 - Differences in SARS-CoV-2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER-Adult Cohort Study.Naomi J Patel, Zoe Swank, Jiaqi Wang, Xiaosong Wang, Lauren A O'Keeffe
Arthritis & Rheumatology. 2026-04-27
Journal Articles
- An international, multispecialty validation study of the IgG4-related disease responder indexWallace ZS, Khosroshahi A, Carruthers MD, Perugino CA, Choi H, Campochiaro C, Culver EL, Cortazar F, Della-Torre E, Ebbo M, Fernandes A, Frulloni L, Hart P, Karadag O,..., Arthritis Care Res, 1/18/2018
- Barriers and facilitators of mentoring for trainees and early career investigators in rheumatology research: Current state, identification of needs, and roadmap to an ...Ogdie A, Sparks JA, Angeles-Han ST, Bush K, Castelino FV, Golding A, Jiang Y, Kahlenberg JM, Kim AHJ, Lee YC, Machireddy K, Ombrello MJ, Shah AA, Wallace ZS, Nigrovic ..., Arthritis Care Res, 1/1/2018
- Lymphomas in IgG4-related disease: clinicopathologic features in a Western populationBledsoe J, Wallace ZS, Stone JH, Deshpande V, Ferry JA, Virchows Arch, 1/28/2017
Books/Book Chapters
Abstracts/Posters
- Multicentric Castleman’s Disease and IgG4-RD: An International Case Exchange ExerciseWallace Z, Third International Symposium on IgG4-Related Disease, Maui, HI, 1/1/2017
- A Trial of XmAb 5871, a Reversible Inhibitor of CD19+ Cells in IgG4-Related DiseaseWallace Z, American College of Rheumatology Annual Meeting, San Diego, CA, 1/1/2017
- Rituximab for the Treatment of IgG4-related and Idiopathic Retroperitoneal Fibrosis.Wallwork R, Wallace ZS, Perugino C, Sharma A, Stone JH, American College of Rheumatology Annual Meeting, San Diego, CA, 1/1/2017
Authored Content
- Reducing Glucocorticoid Duration in Anca-Associated Vasculitis: A Pilot TrialFebruary 2018
- Reducing Glucocorticoid Duration in Anca-Associated Vasculitis: A Pilot TrialFebruary 2018
- Reducing Glucocorticoid Duration in Anca-Associated Vasculitis: A Pilot TrialFebruary 2018
Press Mentions
‘Evidence-Based and Ethically Sound’ Definition of Long COVID Still ‘Too Sensitive’May 30th, 2025
ANCA-Associated Vasculitis: Parsing the Kidney ComplicationsMarch 3rd, 2023- A World of Difference: Updates from the Global Rheumatology SummitJanuary 20th, 2023
Grant Support
- Impact of ANCA Type and Rituximab vs. Cyclophosphamide on Cardiovascular Risk, Mortality, and Quality-Adjusted Life Years inANCA-Associated VasculitisNIAMS2018–2023
- Phenotypes and Biomarkers of IgG4-Related DiseaseRRF2016–2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









